Felipe Batalini, MD
About Felipe Batalini, MD
Felipe Batalini, MD, is a Postdoctoral Scholar specializing in precision medicine and cancer genomics research, currently affiliated with Harvard Medical School and the Broad Institute of MIT and Harvard. He has extensive experience in oncology and has worked at various prestigious institutions, including the Mayo Clinic and Beth Israel Deaconess Medical Center.
Work at Broad Institute
Felipe Batalini serves as a Postdoctoral Scholar at the Broad Institute of MIT and Harvard since 2019. His role involves utilizing genomics and computational biology to advance cancer treatment methodologies. He is engaged in research that focuses on precision medicine, particularly in cancer genomics. Batalini's work at the Broad Institute is part of a broader commitment to improving patient outcomes through innovative research and drug development.
Current Position at Mayo Clinic
Since 2021, Felipe Batalini has been working as a Breast Medical Oncologist at Mayo Clinic in Scottsdale, Arizona. In this role, he applies his expertise in oncology to provide patient care and engage in clinical practices that focus on breast cancer treatment. His experience in both clinical and research settings enhances his ability to contribute to patient care and treatment strategies.
Education and Expertise
Felipe Batalini's educational background includes a Doctor of Medicine (MD) from UEL - Universidade Estadual de Londrina, completed from 2005 to 2010. He furthered his training with a Residency in Internal Medicine at Boston University from 2015 to 2018. Batalini then completed a Clinical & Research Fellowship in Hematology and Oncology at Harvard Medical School from 2018 to 2021. He also studied Genomics and Computational Biology at the Massachusetts Institute of Technology, achieving the status of Postdoctoral Scholar at the Broad Institute from 2019 to 2025.
Previous Experience in Oncology
Prior to his current roles, Felipe Batalini worked as a Clinical Fellow in Hematology and Oncology at Beth Israel Deaconess Medical Center from 2018 to 2021. He also served as an Oncology Hospitalist at Associação de Combate ao Câncer em Goiás (ACCG) from 2011 to 2015. Additionally, he was a Research Fellow at UCLA Health for a brief period in 2014. His diverse experiences in oncology have contributed to his specialization in precision medicine and cancer genomics.
Advisory Role at Harvard Business Review
Felipe Batalini has been an Advisory Council Member at Harvard Business Review since 2019. In this capacity, he provides insights and guidance based on his extensive background in medicine and oncology. His role involves contributing to discussions and initiatives that intersect healthcare and business, reflecting his commitment to advancing knowledge in both fields.